Then, the experimental design was targeted at studying the differences between the lean and obese rats, the effects of habitual exercise or training on the obese rats, and the responses to a single bout of acute exercise performed by the obese sedentary or obese trained animals.
Most of our patients were already on cholesterol-lowering drugs and, as such, they may have achieved the "desired" lipid targets at the study entry.
Partial response (PR) was defined as at least a 30% decrease in the disease measurement for CT/MRI target lesions, taking as reference the disease measurement done to confirm measurable disease in target lesions at study entry.
In general, non-response can take three forms: unit non-response, or absence of the target sample at study outset; temporary or wave non-response; and permanent non-response, commonly referred to as attrition [ 33].
A new target joint was defined as an ankle, knee, elbow or hip joint in which ≥4 bleeding episodes occurred in the same joint within a 6 month period during the study and was not a target joint at study initiation.
I report on a new version of the magnetohydrodynamics code NIRVANA1 which is targeted at the study of astrophysical problems.
Our research methodology is based on the combination of the theoretical contributions of the new growth theory and the NIS approaches, but also benefits from empirical evidence collected during an OECD research project targeted at the study of the Chinese NIS.
This should be distinguished from the phenomenon of contamination, where the control group receives (some of) the intervention targeted at the study group.
Assessment of antitumour activity was evaluated by the same instrumental approach used to evaluate target lesion(s) at study entry and was scored according to the Response Evaluation Criteria in Solid Tumors (RECIST Groupp criteria.
The percentage of patients achieving HbA1c target <7% at study end point was similar between ILPS and comparators in full studies (RR 0.99 [95% CI 0.87 1.12], no heterogeneity: I = 0%), in studies using once-daily insulin dosing (0.96 [0.84–1.08], I = 0%), and in the analysis excluding the abstract (1.065 [0.90–1.25], I = 0%).
